Skip to content

Alinity 09P4120Recalls & reported problems

Abbott Ireland Diagnostics · Alinity i Sirolimus Reagent Kit 200 Tests · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380740150990), received between Jun 3, 2022 and Jun 3, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Low Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 3, 2022Low Test Results; Low Test Results

    THE CUSTOMER OBSERVED FALSELY DECREASED ALINITY I SIROLIMUS RESULTS ON ONE PATIENT SPECIMEN. THE RESULTS PROVIDED WERE: ON (B)(6) 2022. SID (B)(6) =2.98 NG/L /REPEATED=8.05 NG/L /REPEATED FEW TIMES=8.0, 8.1 AND 8.7 NG/L WHICH MATCHED WITH PATIENT¿S PREVIOUS HISTORY. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14591872 ↗

Other Sirolimus test system devices

All Sirolimus test system devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page